MICROBIX BIOSYSTEMS revenue breakdown overview

MICROBIX BIOSYSTEMS revenue for the last year amounted to 25.39 M CAD, the most of which — 15.16 M CAD — came from its highest performing source at the moment, Antigens,Quality Assessment Products and DxTM, the year earlier bringing 19.07 M CAD. The greatest contribution to the revenue figure was made by North America — last year it brought MICROBIX BIOSYSTEMS 10.83 M CAD, and the year before that — 13.14 M CAD.